BUZZ-NRx Pharma tumbles on stock offering plans

NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc.

NRXP

0.00

** NRx Pharmaceuticals' NRXP.O shares down 22% in extended trading to $3.60 as it seeks equity raise

** Biopharma focused on treatments for depression, chronic pain and PTSD announces stock offering; deal size not disclosed

** Co intends to use net offering proceeds for working capital and to support growth

** BTIG lead bookrunner, joined by Lucid Capital Markets

** Delaware-based NRXP has ~36.2 mln shares outstanding for roughly $170 mln market cap

** Stock, which closed flat at $4.62 on Tues, up about 70% YTD

** All 5 analysts covering the stock rate "strong buy" or "buy"; median PT $45, according to LSEG data


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.